- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05698940
Subjective and Objective Outcome of Septoplasty With or Without Infundibulotomy (InfundSPL)
November 30, 2023 updated by: University of Zurich
Subjective and Objective Outcome of Septoplasty With or Without Infundibulotomy/Uncinectomy
Septoplasty is one of the most common procedures in rhinology.
In many centers and private institutions, an infundibulotomy is performed in addition to septoplasty without evidence of significant improvement for the patient.
Often the reason given for this is the improvement of the functional outcome in terms of better nasal breathing, although there is no evidence for this.
If a significantly better outcome can be shown, one would have a first evidence for the extended procedure.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland, 8091
- Recruiting
- Zurich University Hospital
-
Contact:
- Michael Soyka, Dr.med.
- Phone Number: +41 44 255 11 11
- Email: michael.soyka@usz.ch
-
Principal Investigator:
- Michael Soyka, Dr.med.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Unilateral breathing impairment due to septal deviation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Infundibulotomy
Infundibulotomy on one side of sinuses
|
Infundibultomy on one side of patient
|
Sham Comparator: No Infundibultomty
No Intervention on other side of sinuses
|
Infundibultomy on one side of patient
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Single sided VAS Scores for breathing impairment
Time Frame: 3 months
|
Rating of nasal breating on a 0-10 scale
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PNIF
Time Frame: 3 months
|
Peak Nasal Inspiratory Flow measured in ml/sec
|
3 months
|
SNOT Score
Time Frame: 3 months
|
Quality of Life Measure from 0-110
|
3 months
|
NOSE Score
Time Frame: 3 months
|
Nasal symptom questionnaire
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 29, 2016
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
December 27, 2022
First Submitted That Met QC Criteria
January 16, 2023
First Posted (Actual)
January 26, 2023
Study Record Updates
Last Update Posted (Actual)
December 1, 2023
Last Update Submitted That Met QC Criteria
November 30, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK 2015-0356
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasal Obstruction
-
Spirair, IncRecruitingNasal Airway Obstruction | Nasal Septal DeviationUnited States
-
Aerin MedicalOhio State UniversityCompletedNasal ObstructionUnited States
-
Medtronic Surgical TechnologiesCompletedNasal Airway ObstructionUnited States, Canada
-
Aerin MedicalActive, not recruitingNasal ObstructionUnited States
-
Aerin MedicalActive, not recruitingNasal Airway ObstructionUnited States
-
New York City Health and Hospitals CorporationUnknownNasal Airway ObstructionUnited States
-
Yuzuncu Yıl UniversityCompleted
-
Aerin MedicalCompletedNasal ObstructionUnited States
-
Aerin MedicalCompleted
-
HNO-Praxis Alte PostAerin MedicalCompletedNasal Obstruction, BilateralGermany